Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate

類似資料

• A subgroup analysis of the efficacy of filgotinib for patients with moderately active RA following an inadequate response to methotrexate
  著者:: Buch, MH, 等
  出版事項: (2021)
• Filgotinib modulates inflammation-associated peripheral blood protein biomarkers in adults with active rheumatoid arthritis and prior inadequate response to methotrexate
  著者:: Tanaka, Y, 等
  出版事項: (2023)
• Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
  著者:: Yoshiya Tanaka, 等
  出版事項: (2023-07-01)
• Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
  著者:: Yoshiya Tanaka, 等
  出版事項: (2023-11-01)
• Filgotinib for the treatment of rheumatoid arthritis
  著者:: Taylor, P, 等
  出版事項: (2017)